M. Gul

发表

Overcoming drug resistance in hormone- and drug-refractory prostate cancer cell line, PC-3 by docetaxel and gossypol combination

H. Atmaca, S. Uzunoğlu, U. Sanli, 2010, Molecular Biology Reports.

Bisphosphonate (Zoledronic Acid) Associated Adverse Events: Single Center Experience

U. Sanli, R. Uslu, B. Karaca, 2010 .

Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl‐2 protein level in hormone‐refractory prostate cancer cells

H. Atmaca, S. Uzunoğlu, U. Sanli, 2009, Cell biology international.

Increased Susceptibility to Apoptosis and Growth Arrest of Human Breast Cancer Cells Treated by a Snake Venom-Loaded Silica Nanoparticles

Gamal Badr, D. Sayed, D. Maximous, 2014, Cellular Physiology and Biochemistry.

Sorafenib Alleviates Inflammatory Signaling of Tumor Microenvironment in Lung Cancer

M. Kantarci, A. Çetin, S. Yıldırım, 2022 .

Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol.

H. Atmaca, S. Uzunoğlu, U. Sanli, 2008, European cytokine network.

Targeting apoptosis in the hormone‐ and drug‐resistant prostate cancer cell line, DU‐145, by gossypol/zoledronic acid combination

H. Atmaca, S. Uzunoğlu, U. Sanli, 2009, Cell biology international.

Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145

H. Atmaca, S. Uzunoğlu, U. Sanli, 2008, Journal of experimental & clinical cancer research : CR.

Regulation of growth factors in hormone‐ and drug‐resistant prostate cancer cells by synergistic combination of docetaxel and octreotide

H. Atmaca, S. Uzunoğlu, U. Sanli, 2009, BJU international.

Is Oxytocin Proper for Cancer Adjuvant Therapy?

A. Taghizadehghalehjoughi, A. Hacimuftuoglu, B. Çi̇çek, 2018, Proceedings.